Treatment options for acute venous thromboembolism in the older patient

Gian Franco Gensini, Carlo Rostagno, Sabina Caciolli

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The incidence of deep venous thrombosis and pulmonary embolism increases exponentially with age. This pattern reflects the age-related increase in the frequency of serious medical diseases that require prolonged bed rest and predispose to the activation of hemostatic processes. Treatment with heparin and thrombolytic agents is clearly effective in patients age 65 and older, even though an elevated susceptibility to hemorrhagic complications has been demonstrated. Careful evaluation of individual hemorrhagic risk, a slight decrease of doses, and careful laboratory monitoring may decrease the number of clinically significant bleedings without impairing therapeutic results. Low-molecular weight heparin may represent a major advance in the treatment of thromboembolic disease, but studies that specifically address its use in older patients are needed.

Original languageEnglish
Pages (from-to)34-47
Number of pages14
JournalGeriatrics
Volume53
Issue number1
Publication statusPublished - 1998

Fingerprint

Venous Thromboembolism
Bed Rest
Fibrinolytic Agents
Low Molecular Weight Heparin
Hemostatics
Pulmonary Embolism
Venous Thrombosis
Heparin
Therapeutics
Hemorrhage
Incidence

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Gensini, G. F., Rostagno, C., & Caciolli, S. (1998). Treatment options for acute venous thromboembolism in the older patient. Geriatrics, 53(1), 34-47.

Treatment options for acute venous thromboembolism in the older patient. / Gensini, Gian Franco; Rostagno, Carlo; Caciolli, Sabina.

In: Geriatrics, Vol. 53, No. 1, 1998, p. 34-47.

Research output: Contribution to journalArticle

Gensini, GF, Rostagno, C & Caciolli, S 1998, 'Treatment options for acute venous thromboembolism in the older patient', Geriatrics, vol. 53, no. 1, pp. 34-47.
Gensini GF, Rostagno C, Caciolli S. Treatment options for acute venous thromboembolism in the older patient. Geriatrics. 1998;53(1):34-47.
Gensini, Gian Franco ; Rostagno, Carlo ; Caciolli, Sabina. / Treatment options for acute venous thromboembolism in the older patient. In: Geriatrics. 1998 ; Vol. 53, No. 1. pp. 34-47.
@article{4ba1e05c6eb547db9c76aaab10bff1b1,
title = "Treatment options for acute venous thromboembolism in the older patient",
abstract = "The incidence of deep venous thrombosis and pulmonary embolism increases exponentially with age. This pattern reflects the age-related increase in the frequency of serious medical diseases that require prolonged bed rest and predispose to the activation of hemostatic processes. Treatment with heparin and thrombolytic agents is clearly effective in patients age 65 and older, even though an elevated susceptibility to hemorrhagic complications has been demonstrated. Careful evaluation of individual hemorrhagic risk, a slight decrease of doses, and careful laboratory monitoring may decrease the number of clinically significant bleedings without impairing therapeutic results. Low-molecular weight heparin may represent a major advance in the treatment of thromboembolic disease, but studies that specifically address its use in older patients are needed.",
author = "Gensini, {Gian Franco} and Carlo Rostagno and Sabina Caciolli",
year = "1998",
language = "English",
volume = "53",
pages = "34--47",
journal = "Geriatrics",
issn = "0016-867X",
publisher = "Advanstar Communications",
number = "1",

}

TY - JOUR

T1 - Treatment options for acute venous thromboembolism in the older patient

AU - Gensini, Gian Franco

AU - Rostagno, Carlo

AU - Caciolli, Sabina

PY - 1998

Y1 - 1998

N2 - The incidence of deep venous thrombosis and pulmonary embolism increases exponentially with age. This pattern reflects the age-related increase in the frequency of serious medical diseases that require prolonged bed rest and predispose to the activation of hemostatic processes. Treatment with heparin and thrombolytic agents is clearly effective in patients age 65 and older, even though an elevated susceptibility to hemorrhagic complications has been demonstrated. Careful evaluation of individual hemorrhagic risk, a slight decrease of doses, and careful laboratory monitoring may decrease the number of clinically significant bleedings without impairing therapeutic results. Low-molecular weight heparin may represent a major advance in the treatment of thromboembolic disease, but studies that specifically address its use in older patients are needed.

AB - The incidence of deep venous thrombosis and pulmonary embolism increases exponentially with age. This pattern reflects the age-related increase in the frequency of serious medical diseases that require prolonged bed rest and predispose to the activation of hemostatic processes. Treatment with heparin and thrombolytic agents is clearly effective in patients age 65 and older, even though an elevated susceptibility to hemorrhagic complications has been demonstrated. Careful evaluation of individual hemorrhagic risk, a slight decrease of doses, and careful laboratory monitoring may decrease the number of clinically significant bleedings without impairing therapeutic results. Low-molecular weight heparin may represent a major advance in the treatment of thromboembolic disease, but studies that specifically address its use in older patients are needed.

UR - http://www.scopus.com/inward/record.url?scp=0031960073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031960073&partnerID=8YFLogxK

M3 - Article

C2 - 9442762

AN - SCOPUS:0031960073

VL - 53

SP - 34

EP - 47

JO - Geriatrics

JF - Geriatrics

SN - 0016-867X

IS - 1

ER -